Clinicopathologic study of von Hippel-Lindau syndrome-related and sporadic hemangioblastomas of central nervous system

Chinese Journal of Pathology

Volumn 39, Issue 3, 2010, Pages 145-150

  Zhou, Jing ^a   Li, Nan Yun ^a   Zhou, Xiao Jun ^a   Zhou, Hang Bo ^a   Wu, Bo ^a   Jiang, Shao Jun ^a   Ma, Heng Hui ^a   Zhang, Ru Song ^a  

^a Clinical School   (China)

Author keywords

Hemangioblastoma; Immunohistochemistry; Prognosis; Von Hippel Lindau syndrome

Indexed keywords

EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; INHIBIN; INHIBIN ALPHA SUBUNIT; INHIBIN-ALPHA SUBUNIT; KI 67 ANTIGEN; VIMENTIN;

ADOLESCENT; ADULT; ARTICLE; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; FEMALE; FOLLOW UP; HEMANGIOBLASTOMA; HUMAN; KIDNEY CARCINOMA; MALE; METABOLISM; MIDDLE AGED; PANCREAS TUMOR; PATHOLOGY; RETINA TUMOR; SURVIVAL; TUMOR RECURRENCE; VON HIPPEL LINDAU DISEASE;

ADOLESCENT; ADULT; CARCINOMA, RENAL CELL; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; FEMALE; FOLLOW-UP STUDIES; GLIAL FIBRILLARY ACIDIC PROTEIN; HEMANGIOBLASTOMA; HUMANS; INHIBINS; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PANCREATIC NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETINAL NEOPLASMS; SURVIVAL ANALYSIS; VIMENTIN; VON HIPPEL-LINDAU DISEASE; YOUNG ADULT;

EID: 77950192512     PISSN: 05295807     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0529-5807.2010.03.001     Document Type: Article

References (14)

1. Louis DN, Ohgaki H, Wiestler OD. et al. WHO classification of tumours of the central nervous system. Lyon: IARC Press, 2007:184-186, 215-217.
2. Leung RS, Biswas SV, Duncan M, et al. Imaging features of von Hippel-Lindau disease. Radiographics, 2008, 28 (1):65-79.
3. Conway JE, Chou D, Clatterbuck RE, et al. Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease. Neurosurgery, 2001, 48 (1):55-62.
4. Sora S, Ueki K, Saito N, et al. Incidence of von Hippel-Lindau disease in hemangioblastoma patients; the University of Tokyo Hospital experience from 1954-1998. Acta Neurochir (Wien), 2001, 143 (9):893-896.
5. Melmon KL, Rosen SW. Lindau's disease. Review of the literature and study of a large kindred. Am J Med, 964, 36:595-617.
6. Richard S, Graff J, Lindau J, et al. Von Hippel-Lindau disease. Lancet, 2004, 363 (9416):1231-1234.
7. Richard S, Campello C, Taillandier L, et al. Haemangioblastoma of the central nervous system in von Hippel-Lindau disease. French VHL Study Group. J Intern Med, 1998, 243 (6):547-553.
8. Ishizawa K. Komori T. Hirose T. Stromal cells in hemangioblastoma: neuroectodermal differentiation and morphological similarities to ependymoma. Pathol Int, 2005, 55 (7); 377-385.
9. Roy S, Chu A, Trojanowski JQ, et al. D2-40, a novel monoclonal antibody against the M2A antigen as a marker to distinguish hemangioblastomas from renal cell carcinomas. Acta Neuropathol, 2005, 109 (5):497-502.
10. Weinbreck N, Marie B, Bressenot A, et al. Immunohistochemical markers to distinguish between hemangioblastoma and metastatic clear-cell renal cell carcinoma in the brain: utility of aquaporinl combined with cytokeratin AE1/AE3 immunostaining. Am J Surg Pathol, 2008, 32 (7):1051-1059.
11. Hoang MP, Amirknan RH. Inhibin alpha distinguishes hemangioblastoma from clear cell renal cell carcinoma. Am J Surg Pathol, 2003, 27 (8):1152-1156.
12. Barnes L. Eveson JW, Reichart P, et al. Pathology and genetics of head and neck tumours. Lyon;IARC Press, 2005:355-356.